159 related articles for article (PubMed ID: 11161400)
1. Decreased expression of the Id3 gene at 1p36.1 in ovarian adenocarcinomas.
Arnold JM; Mok SC; Purdie D; Chenevix-Trench G
Br J Cancer; 2001 Feb; 84(3):352-9. PubMed ID: 11161400
[TBL] [Abstract][Full Text] [Related]
2. Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas.
Arnold JM; Cummings M; Purdie D; Chenevix-Trench G
Br J Cancer; 2001 Nov; 85(9):1351-8. PubMed ID: 11720474
[TBL] [Abstract][Full Text] [Related]
3. Autocrine BMP4 signalling regulates ID3 proto-oncogene expression in human ovarian cancer cells.
Shepherd TG; Thériault BL; Nachtigal MW
Gene; 2008 May; 414(1-2):95-105. PubMed ID: 18372118
[TBL] [Abstract][Full Text] [Related]
4. Profiling follicle stimulating hormone-induced gene expression changes in normal and malignant human ovarian surface epithelial cells.
Ho SM; Lau KM; Mok SC; Syed V
Oncogene; 2003 Jul; 22(27):4243-56. PubMed ID: 12833147
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer.
Lai J; Flanagan J; Phillips WA; Chenevix-Trench G; Arnold J
Br J Cancer; 2003 Jan; 88(2):270-6. PubMed ID: 12610513
[TBL] [Abstract][Full Text] [Related]
6. Reduced transcription of the RB2/p130 gene in human lung cancer.
Xue Jun H; Gemma A; Hosoya Y; Matsuda K; Nara M; Hosomi Y; Okano T; Kurimoto F; Seike M; Takenaka K; Yoshimura A; Toyota M; Kudoh S
Mol Carcinog; 2003 Nov; 38(3):124-9. PubMed ID: 14587097
[TBL] [Abstract][Full Text] [Related]
7. RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer.
Bignone PA; Lee KY; Liu Y; Emilion G; Finch J; Soosay AE; Charnock FM; Beck S; Dunham I; Mungall AJ; Ganesan TS
Oncogene; 2007 Feb; 26(5):683-700. PubMed ID: 16878154
[TBL] [Abstract][Full Text] [Related]
8. Global analysis of chromosome X gene expression in primary cultures of normal ovarian surface epithelial cells and epithelial ovarian cancer cell lines.
Benoît MH; Hudson TJ; Maire G; Squire JA; Arcand SL; Provencher D; Mes-Masson AM; Tonin PN
Int J Oncol; 2007 Jan; 30(1):5-17. PubMed ID: 17143508
[TBL] [Abstract][Full Text] [Related]
9. Absence of p51 alteration in human ovarian cancer.
Shinozaki H; Okamoto A; Shimizu K; Saito M; Yokota J; Ochiai K
Int J Oncol; 2001 Mar; 18(3):549-52. PubMed ID: 11179485
[TBL] [Abstract][Full Text] [Related]
10. Differential gene expression between normal and tumor-derived ovarian epithelial cells.
Ismail RS; Baldwin RL; Fang J; Browning D; Karlan BY; Gasson JC; Chang DD
Cancer Res; 2000 Dec; 60(23):6744-9. PubMed ID: 11118061
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological significance of circadian rhythm-related gene expression levels in patients with epithelial ovarian cancer.
Tokunaga H; Takebayashi Y; Utsunomiya H; Akahira J; Higashimoto M; Mashiko M; Ito K; Niikura H; Takenoshita S; Yaegashi N
Acta Obstet Gynecol Scand; 2008; 87(10):1060-70. PubMed ID: 18720043
[TBL] [Abstract][Full Text] [Related]
12. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
[TBL] [Abstract][Full Text] [Related]
13. Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy.
Bignotti E; Tassi RA; Calza S; Ravaggi A; Romani C; Rossi E; Falchetti M; Odicino FE; Pecorelli S; Santin AD
Gynecol Oncol; 2006 Nov; 103(2):405-16. PubMed ID: 16725184
[TBL] [Abstract][Full Text] [Related]
14. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
15. Expression and function of HOXA genes in normal and neoplastic ovarian epithelial cells.
Ota T; Klausen C; Salamanca MC; Woo HL; Leung PC; Auersperg N
Differentiation; 2009 Feb; 77(2):162-71. PubMed ID: 19281776
[TBL] [Abstract][Full Text] [Related]
16. Trichostatin A modulates expression of p21waf1/cip1, Bcl-xL, ID1, ID2, ID3, CRAB2, GATA-2, hsp86 and TFIID/TAFII31 mRNA in human lung adenocarcinoma cells.
Eickhoff B; Rüller S; Laue T; Köhler G; Stahl C; Schlaak M; van der Bosch J
Biol Chem; 2000 Feb; 381(2):107-12. PubMed ID: 10746741
[TBL] [Abstract][Full Text] [Related]
17. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
[TBL] [Abstract][Full Text] [Related]
18. Establishment and characterization of human ovarian carcinoma cell lines.
Yuan Y; Kim WH; Han HS; Lee JH; Park HS; Chung JK; Kang SB; Park JG
Gynecol Oncol; 1997 Sep; 66(3):378-87. PubMed ID: 9299249
[TBL] [Abstract][Full Text] [Related]
19. Roles of KLF6 and KLF6-SV1 in ovarian cancer progression and intraperitoneal dissemination.
DiFeo A; Narla G; Hirshfeld J; Camacho-Vanegas O; Narla J; Rose SL; Kalir T; Yao S; Levine A; Birrer MJ; Bonome T; Friedman SL; Buller RE; Martignetti JA
Clin Cancer Res; 2006 Jun; 12(12):3730-9. PubMed ID: 16778100
[TBL] [Abstract][Full Text] [Related]
20. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]